Innovative Platforms for Rapid and Cost-Effective HTP Antibody & Protein Production
As the field of biologics development evolves rapidly, there is increasing demand for high-throughput (HTP) antibody and protein production that is fast and cost-effective. This webinar showcases two innovative HTP antibody and protein production platforms: Ultra 96 and 7-7-7. Both platforms are powered by our ultra-high titer transient CHO system and designed for fast, affordable production. The Ultra 96 platform, with its 96- and 24-DWP format, quickly produces hundreds to thousands of antibodies per run at 100-1,500 µg each. The 7-7-7 offers low endotoxin and aggregates antibody production at 1-100 mg scale. Each platform addresses challenges at different stages of drug discovery, accelerating your drug development journey.
In this webinar, you will learn:
- How the Ultra 96 and 7-7-7 platforms combine speed, purity, and scalability to streamline the biologics discovery process.
- Strategies for efficient high-throughput antibody/protein production that align with current trends and demands in biologic drug development.
- Case studies that demonstrate the successful application of Ultra 96 and 7-7-7 platforms in producing a large number of biologics rapidly and cost-effectively.
Julia Su, Ph.D., Associate Director, Protein Sciences